Moleculin Biotech, Inc. Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount
Moleculin Biotech, Inc. (MBRX) reported Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount of $329.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount · last filed 2026-08-13
- Moleculin Biotech, Inc. warrant down round feature decrease in net income loss to common shareholder amount for the quarter ending 2026-06-30 was $329.00K.
- Moleculin Biotech, Inc. warrant down round feature decrease in net income loss to common shareholder amount for the quarter ending 2026-03-31 was $1.76M.
- Moleculin Biotech, Inc. warrant down round feature decrease in net income loss to common shareholder amount for the quarter ending 2025-06-30 was $0.00.
- Moleculin Biotech, Inc. warrant down round feature decrease in net income loss to common shareholder amount for the quarter ending 2025-03-31 was $0.00.
| Period end | Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount 3 month | Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount 6 month |
|---|---|---|
| 2026-06-30 | $329.00K 10-Q · filed 2026-08-13 | $2.09M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.76M 10-Q · filed 2026-05-14 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |